Ellis Investment Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 438 |
|
|
2022
Q3 | – | Sell |
-131
| Closed | -$3K | – | 810 |
|
|
2022
Q2 | $3K | Buy |
131
+1
| +0.8% | +$23 | ﹤0.01% | 707 |
|
|
2022
Q1 | $4K | Hold |
130
| – | – | ﹤0.01% | 711 |
|
|
2021
Q4 | $5K | Sell |
130
-600
| -82% | -$23.1K | ﹤0.01% | 695 |
|
|
2021
Q3 | $37K | Buy |
730
+300
| +70% | +$15.2K | 0.01% | 434 |
|
|
2021
Q2 | $22K | Buy |
430
+300
| +231% | +$15.3K | 0.01% | 500 |
|
|
2021
Q1 | $6K | Hold |
130
| – | – | ﹤0.01% | 640 |
|
|
2020
Q4 | $6K | Hold |
130
| – | – | ﹤0.01% | 615 |
|
|
2020
Q3 | $5K | Buy |
+130
| New | +$5K | ﹤0.01% | 623 |
|